Skip to main content
. 2016 Jun 23;7(34):54488–54502. doi: 10.18632/oncotarget.10239

Figure 4. Expression of PLIN1 in breast cancer.

Figure 4

Compared with normal tissue (A), immunohistochemical staining revealed a significantly reduced staining area of PLIN1 in HER2-E (B), basal-like (C), luminal A (D) and luminal B (E) subtypes. HER2 staining was used as a control.